2006
DOI: 10.1586/17434440.3.3.267
|View full text |Cite
|
Sign up to set email alerts
|

Towards optimization of the thrombogenic potential of blood recirculating cardiovascular devices using modeling approaches

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
18
0

Year Published

2008
2008
2016
2016

Publication Types

Select...
8

Relationship

7
1

Authors

Journals

citations
Cited by 19 publications
(18 citation statements)
references
References 15 publications
0
18
0
Order By: Relevance
“…The model of Equation 2 states that platelet activation time course is predicted by a function of the unknown parameter vector P, where (6) is the estimated value of platelet activation at time t i (i = 1,. . .…”
Section: Model Identification Protocolmentioning
confidence: 99%
See 1 more Smart Citation
“…The model of Equation 2 states that platelet activation time course is predicted by a function of the unknown parameter vector P, where (6) is the estimated value of platelet activation at time t i (i = 1,. . .…”
Section: Model Identification Protocolmentioning
confidence: 99%
“…Such an approach should incorporate a model accounting for cellular trauma by means of an activation/damage accumulation hypothesis. 6 Recently, our group has published a comparison of the hemodynamic and thrombogenic performance of two bileaflet mechanical heart valve (MHV) using fluid structure interaction (FSI) modeling that involved the computation of damage accumulation along the trajectories of 15,000 platelets. 7 Correctly implemented, a physically consistent mathematical model for predicting the effects of fluid shear stress on platelets may lead to a better understanding of the phenomenology of thrombosis.…”
mentioning
confidence: 99%
“…Due to the complexity and the variety of phenomena involved, a universal approach to the problem was (i) incongruous, due to the inherent limitations of mathematical models based only on steady state shear-induced trauma (Grigioni et al, 2004a), and/or (ii) of limited value, due to simplified geometric models/working conditions of the investigated devices (Grigioni et al, 2005a;Dasi et al, 2007). Hence, in the absence of a clear methodology for quantifying the thrombogenic potential of blood re-circulating devices, MHVs are still not necessarily optimized for flow-induced thrombogenicity (Bluestein, 2004(Bluestein, , 2006, and patients receiving even the most up to date designs of MHV still require anticoagulant medication due to the risk of thrombogenic complications and cardioembolic stroke.…”
Section: Introductionmentioning
confidence: 99%
“…The purpose of the HSD, as discussed in this review, is to be able to replicate shear-stress patterns in and around PHV and other cardiovascular prosthetic devices geometries calculated numerically using novel approaches as discussed previously by the author [117]. Once design optimization has been achieved numerically to minimize the predicted cumulative platelet damage in recirculation devices and PHV [74], the dynamic shear stress information can be fed to the HSD and the effect of such localized stress trajectories on platelet activation can be accurately assessed in vitro.…”
Section: Expert Commentarymentioning
confidence: 99%